# An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence

> **NCT00847535** · PHASE2 · COMPLETED · sponsor: **Cook MyoSite** · enrollment: 66 (actual)

## Conditions studied

- Stress Urinary Incontinence
- Cell Therapy

## Interventions

- **BIOLOGICAL:** autologous muscle cell injection

## Key facts

- **NCT ID:** NCT00847535
- **Lead sponsor:** Cook MyoSite
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10-09
- **Primary completion:** 2011-11-02
- **Final completion:** 2011-11-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847535, "An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00847535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*